The JSE had its third day of gains on Tuesday as progress in creating a Covid-19 vaccine and the EU’s stimulus deal boosted appetite for riskier assets.
Markets rallied following reports that an experimental vaccine trial by Oxford University and British-Swedish pharmaceutical group AstraZeneca induced an immune response. Data showed that a vaccine trial by German BioNTech and US pharmaceutical firm Pfizer also showed positive results and that it is safe for humans.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
MARKET WRAP: JSE firms on ongoing stimulus talks‘The dollar was firmer against most currencies today with the exception of the euro as markets await the outcome of EU stimulus talks’
Source: BDliveSA - 🏆 12. / 63 Read more »
Source: eNCA - 🏆 49. / 51 Read more »
Market rebound helps lift Ninety One and CoronationNinety One assets under management rose to £118bn during the prior quarter, while Coronation's increased to R570bn
Source: BDliveSA - 🏆 12. / 63 Read more »
WATCH: How lockdown has laid waste to the labour marketPrincipal investigator of the NIDS CRAM project Nic Spaull talks to Business Day TV about what their survey revealed.
Source: BDliveSA - 🏆 12. / 63 Read more »
Market rebound helps lift Ninety One and CoronationNinety One assets under management rose to £118bn during the prior quarter, while Coronation's increased to R570bn
Source: BDliveSA - 🏆 12. / 63 Read more »